Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 283,650 | 268,272 | 406,925 | 152,822 | 217,058 |
| Receivables | 708,045 | 583,898 | 724,407 | 606,157 | 520,247 |
| Inventories | 475,760 | 443,956 | 437,959 | 381,067 | 401,827 |
| TOTAL | $1,543,719 | $1,480,874 | $1,773,700 | $1,210,210 | $1,205,831 |
| Non-Current Assets | |||||
| PPE Net | 462,438 | 460,528 | 467,559 | 477,997 | 490,712 |
| Intangibles | 1,871,803 | 1,951,301 | 1,989,894 | 1,802,257 | 1,855,472 |
| Other Non-Current Assets | 159,576 | 164,053 | 159,647 | 175,426 | 151,928 |
| TOTAL | $2,493,817 | $2,575,882 | $2,617,100 | $2,455,680 | $2,498,112 |
| Total Assets | $4,037,536 | $4,056,756 | $4,390,800 | $3,665,890 | $3,703,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,776 | 30,756 | 30,736 | 21,479 | 21,468 |
| Accounts payable and accrued liabilities | 621,688 | 607,944 | 618,120 | 513,452 | 496,622 |
| Other current liabilities | N/A | N/A | 4,084 | N/A | N/A |
| TOTAL | $667,886 | $655,019 | $965,065 | $550,406 | $534,910 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,793,187 | 2,800,239 | 2,807,310 | 2,609,046 | 2,614,412 |
| Other Non-Current Liabilities | 167,777 | 181,648 | 147,448 | 130,962 | 195,564 |
| TOTAL | $3,021,454 | $3,030,721 | $3,022,277 | $2,768,696 | $2,773,309 |
| Total Liabilities | $3,689,340 | $3,685,740 | $3,987,342 | $3,319,102 | $3,308,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 299,745 | 299,656 | 299,431 | 299,226 | 299,100 |
| Common Shares | 2,997 | 2,996 | 2,994 | 2,992 | 2,991 |
| Retained earnings | -283,784 | -274,809 | -262,813 | -377,880 | -345,752 |
| Other shareholders' equity | 5,850 | 25,325 | 51,677 | 114,710 | 172,844 |
| TOTAL | $348,196 | $371,016 | $403,458 | $346,788 | $395,724 |
| Total Liabilities And Equity | $4,037,536 | $4,056,756 | $4,390,800 | $3,665,890 | $3,703,943 |